Coinfection of Mycobacterium malmoense and Mycobacterium chimaera in a kidney transplant recipient: A case report and review of the literature.
Coinfection
/ diagnosis
Humans
Immunosuppression Therapy
Kidney Transplantation
/ adverse effects
Male
Middle Aged
Mycobacterium
/ isolation & purification
Mycobacterium Infections, Nontuberculous
/ diagnostic imaging
Positron Emission Tomography Computed Tomography
Respiratory Tract Infections
/ diagnosis
Urinary Tract Infections
/ diagnosis
Mycobacterium chimaera
Mycobacterium malmoense
kidney transplantation
nontuberculous mycobacteria
solid organ transplant
Journal
Transplant infectious disease : an official journal of the Transplantation Society
ISSN: 1399-3062
Titre abrégé: Transpl Infect Dis
Pays: Denmark
ID NLM: 100883688
Informations de publication
Date de publication:
Apr 2020
Apr 2020
Historique:
received:
16
05
2019
revised:
03
12
2019
accepted:
26
12
2019
pubmed:
3
1
2020
medline:
21
11
2020
entrez:
3
1
2020
Statut:
ppublish
Résumé
Nontuberculous mycobacteria (NTM) are ubiquitous organisms found in soil and water. Solid organ recipients are at increased risk of NTM infections due to impaired immunity. Although the NTM infections rate is low, it increases morbidity and the risk of mortality. Diagnosis is often delayed because of the lack of specific clinical symptoms and requires a high index of suspicion. Management may be challenging: long-term treatment with risks of side effects and interactions with immunosuppressive regimen; reduction of immunosuppression; and risk of allograft rejection. Prognosis is widely variable. We report the first case of Mycobacterium malmoense chest infection with concomitant Mycobacterium chimaera urinary tract infection in a kidney transplant recipient. The evolution was marked by poor tolerance of the treatment with severe adverse events and disabled functional status.
Types de publication
Case Reports
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13241Informations de copyright
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Références
Daley CL. Nontuberculous mycobacterial disease in transplant recipients: early diagnosis and treatment. Curr Opin Organ Transplant. 2009;14:619-624.
Dorman S, Subramanian A. and the AST infectious diseases community of practice. Nontuberculous mycobacteria in solid organ transplant recipients. Am J Transplant. 2009;9(suppl 4):S63-S69.
Doucette K, Fishman J. Nontuberculous mycobacterial infection in hematopoietic stem cell and solid organ transplant recipients. Clin Infect Dis. 2004;38:1428-1439.
Fan M, Hadjiliadis D. Incidence and management of mycobacterial infection in solid organ transplant recipients. Curr Infect Dis Rep. 2009;11:216-222.
Keating M, Daly J, AST Infectious Diseases Community of Practice. Nontuberculous mycobacterial infections in solid organ transplantation. Am J Transplant. 2013;13:77-82.
Griffith D, Aksamit T, Brown-Elliot B, et al. An Official ATS/IDSA Statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367-416.
Ho T, Rommelaere M, Coche E, et al. Nontuberculous mycobacterial pulmonary infection in renal transplant recipients. Transpl Infect Dis. 2010;12:138-142.
Wilmes D, Coche E, Rodriguez-Villalobos H, et al. Bacterial pneumonia in kidney transplant recipients. Respir Med. 2018;137:89-94.
Longworth SA, Blumberg EA, Barton TD, et al. Nontuberculous mycobacterial infections after solid organ transplantation: a survival analysis. Clin Microbiol Infect. 2015;21:43-47.
Longworth SA, Vinnard C, Lee I, et al. Risk factors for nontuberculous mycobacterial infections in solid organ transplant recipients: a case-control study. Transpl Infect Dis. 2014;16:76-83.
Schroder KH, Juhlin I Mycobacterium malmoense sp. nov. Int J Syst Bacteriol. 1977;27:241-246.
Wayne L, Sramek H. Agents of newly recognized or infrequently encountered mycobacterial diseases. Clin Microbiol Rev. 1992;5:1-25.
Hoefsloot W, Boeree MJ, van Ingen J, et al. The rising incidence and clinical relevance of Mycobacterium malmoense: a review of the literature. Int J Tuberc Lung Dis. 2008;12:987-993.
Hoefsloot W, van Ingen J, de Lange W, et al. Clinical relevance of Mycobacterium malmoense isolation in the Netherlands. Eur Respir J. 2009;34:926-931.
van Grootveld R, Scherer HU, Peters EEM, et al. Tenosynovitis caused by Mycobacterium malmoense in two kidney transplant recipients and review of the literature. Transpl Infect Dis. 2018;20:e12810.
Tortoli E, Rindi L, Garcia MJ, et al. Proposal to elevate the genetic variant MAC-A, included in the Mycobacterium avium complex, to species rank as Mycobacterium chimaera sp. nov. Int J Syst Evol Microbiol. 2004;54:1277-1285.
Schweickert B, Goldenberg O, Richter E, et al. Occurrence and clinical relevance of Mycobacterium chimaera sp. nov., Germany. Emerg Infect Dis. 2008;14:1443-1446.
Soetaert K, Vluggen C, Andre E, et al. Frequency of Mycobacterium chimaera among Belgian patients, 2015. J Med Microbiol. 2016;65:1307-1310.
Boyle D, Zembower TR, Reddy S, et al. Comparison of clinical features, virulence, and relapse among Mycobacterium avium complex species. Am J Respir Crit Care Med. 2015;191:1310-1317.
Moon S, Kim SY, Jhun BW, et al. Clinical characteristics and treatment outcomes of pulmonary disease caused by Mycobacterium chimaera. Diagn Microb and Infect Dis. 2016;86:382-384.
Kohler P, Kuster S, Bloemberg G, et al. Healthcare-associated prosthetic heart valve, aortic vascular graft, and disseminated Mycobacterium chimaera infections subsequent to open heart surgery. Eur Heart J. 2015;36:2745-2753.